- Home
- IVDA vs PPBT Comparison
IVDA vs PPBT Comparison
Compare IVDA & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- PPBT
- Stock Information
- Founded
- IVDA 2003
- PPBT 2010
- Country
- IVDA United States
- PPBT Israel
- Employees
- IVDA N/A
- PPBT N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- PPBT Health Care
- Exchange
- IVDA Nasdaq
- PPBT Nasdaq
- Market Cap
- IVDA 6.7M
- PPBT 6.2M
- IPO Year
- IVDA N/A
- PPBT N/A
- Fundamental
- Price
- IVDA $1.70
- PPBT $2.31
- Analyst Decision
- IVDA
- PPBT Strong Buy
- Analyst Count
- IVDA 0
- PPBT 1
- Target Price
- IVDA N/A
- PPBT $33.00
- AVG Volume (30 Days)
- IVDA 42.6K
- PPBT 269.4K
- Earning Date
- IVDA 08-14-2025
- PPBT 08-06-2025
- Dividend Yield
- IVDA N/A
- PPBT N/A
- EPS Growth
- IVDA N/A
- PPBT N/A
- EPS
- IVDA N/A
- PPBT N/A
- Revenue
- IVDA $7,142,302.00
- PPBT N/A
- Revenue This Year
- IVDA $340.48
- PPBT N/A
- Revenue Next Year
- IVDA N/A
- PPBT N/A
- P/E Ratio
- IVDA N/A
- PPBT N/A
- Revenue Growth
- IVDA 88.96
- PPBT N/A
- 52 Week Low
- IVDA $1.27
- PPBT $2.00
- 52 Week High
- IVDA $8.05
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- IVDA 35.96
- PPBT 49.88
- Support Level
- IVDA $1.72
- PPBT $2.11
- Resistance Level
- IVDA $1.87
- PPBT $2.31
- Average True Range (ATR)
- IVDA 0.13
- PPBT 0.16
- MACD
- IVDA -0.02
- PPBT 0.01
- Stochastic Oscillator
- IVDA 5.26
- PPBT 72.73
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.